Innovation in the current Congress is practically a dirty word, as almost nothing encouraging it has made it past both houses. Most notably of all, the Innovation Act has been stalled in the House for years, despite massive bipartisan support…

As anyone who’s followed the long-standing battle to fix America’s patent system and cut off abuses by bottom-feeding legal parasites and abusive monopolists will tell you, the list of excuses for our broken system offered by those people is seemingly…

America’s pharmaceutical industry has a problem, and that problem is the rule of law. One can draw no other conclusion, based on the industry’s recent actions. I refer specifically to the pharmaceutical company Allergan’s recent optically baffling attempt to outright…

Here’s a simple question for you: If, every time you faced a particular court, it found against you either unanimously or close to it, would you not do anything possible to avoid that court? To most people, the answer to…

President Donald Trump’s recent decision to investigate China’s theft of American intellectual property (IP) is as good a sign as any that “America First” was more than just a campaign slogan. And when it comes to intellectual property theft, the…

When the U.S. Supreme Court handed down the landmark case TC Heartland v. Kraft earlier this year, patent reform advocates breathed a sigh of relief. Here, at last, was the unanimous smackdown that would put an end to venue shopping…

When it comes to the area of patent law, the Trump touch is desperately needed. No living politician has shown a better capacity to cut through the rationalizations of Leftists, legalistic regulators, and special interests to find a solution that…

With healthcare reform now back on the docket in the U.S. Senate, liberals are crying bloody murder over the purely hypothetical costs to the insured that exist entirely in their heads. But they’re not wrong about one thing: healthcare is…

Defense of today’s patent system can be a difficult job. At its best, the system can encourage innovation, protect the sacred rights of inventors, and do it highly effectively. At its worst, it falls prey to loopholes and day-to-day issues…

This past Friday, some little-noticed good news came from the infant Trump administration: U.S. Patent and Trademark Office (USPTO) director Michelle Lee will be staying on under the new president. It was a move that, similarly to President Trump’s decision…